These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prevalence of cytomegalovirus (CMV) infection among neonatal intensive care unit (NICU) and healthcare workers. Morgan MA; el-Ghany el-SM; Khalifa NA; Sherif A; Rasslan LR Egypt J Immunol; 2003; 10(2):1-8. PubMed ID: 15719606 [TBL] [Abstract][Full Text] [Related]
12. [Can we rule out a congenital cytomegalovirus infection when the result of polymerase chain reaction in dried blood spots is negative?]. Vives-Oñós I; Soler-Palacín P; Codina-Grau MG; Martín-Nalda A; López-Galera RM; Marín-Soria JL; Figueras-Nadal C Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):570-3. PubMed ID: 24268671 [TBL] [Abstract][Full Text] [Related]
13. Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study. Barlinn R; Dudman SG; Trogstad L; Gibory M; Muller F; Magnus P; Rollag H APMIS; 2018 Dec; 126(12):899-906. PubMed ID: 30378168 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404 [TBL] [Abstract][Full Text] [Related]
15. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program. Rawlinson WD; Palasanthiran P; Hall B; Al Yazidi L; Cannon MJ; Cottier C; van Zuylen WJ; Wilkinson M J Clin Virol; 2018 May; 102():110-115. PubMed ID: 29571077 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay. Nagel A; Dimitrakopoulou E; Teig N; Kern P; Lücke T; Michna D; Korn K; Steininger P; Shahada K; Neumann K; Überla K PLoS One; 2020; 15(1):e0227143. PubMed ID: 31917817 [TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva. Leruez-Ville M; Magny JF; Couderc S; Pichon C; Parodi M; Bussières L; Guilleminot T; Ghout I; Ville Y Clin Infect Dis; 2017 Aug; 65(3):398-404. PubMed ID: 28419213 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina: A Single-Center Experience. Arapović J; Rajič B; Pati S; Brizić I; Azinović I; Šušak B; Ostojić M; Tutiš B; Raguž AB; Tomić V; Jonjić S; Boppana S Pediatr Infect Dis J; 2020 Feb; 39(2):140-144. PubMed ID: 31738327 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Pathirana J; Groome M; Dorfman J; Kwatra G; Boppana S; Cutland C; Jones S; Madhi SA Clin Infect Dis; 2019 Oct; 69(10):1789-1796. PubMed ID: 30615106 [TBL] [Abstract][Full Text] [Related]
20. Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening. Ari-Even Roth D; Lubin D; Kuint J; Teperberg-Oikawa M; Mendelson E; Strauss T; Barkai G Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F519-F524. PubMed ID: 28468898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]